PDF herunterladen
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2022; 43(04): 355-360
DOI: 10.1055/s-0042-1755302
Original Article

Fear of Recurrence and Somatic Symptom Severity in Multiple Myeloma Patients: An Institution-Based Cross-Sectional Study

Praveen Kumar Shenoy V P 
1   Department of Clinical Hematology and Medical Oncology, Malabar Cancer Centre, Thalassery, Kannur, Kerala, India
,
Vineetha Raghavan
1   Department of Clinical Hematology and Medical Oncology, Malabar Cancer Centre, Thalassery, Kannur, Kerala, India
,
Avaronnan Manuprasad
1   Department of Clinical Hematology and Medical Oncology, Malabar Cancer Centre, Thalassery, Kannur, Kerala, India
,
Sajeev Kumar P. B.
2   Department of Psychiatry, Aster MIMS, Kannur, Kerala, India
,
Zoheb Raj
3   Department of Psychiatry, KMCT Medical College, Kozhikode, Kerala, India
,
Chandran K. Nair
1   Department of Clinical Hematology and Medical Oncology, Malabar Cancer Centre, Thalassery, Kannur, Kerala, India
› Institutsangaben Funding None.
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Introduction Psychosocial concerns especially fear of cancer recurrence (FCR) is less commonly addressed among patients with multiple myeloma in India. Myeloma being incurable, an understanding of this problem is essential for adequately addressing them.

Objectives To study the prevalence of FCR among patients with multiple myeloma and determine the prevalence of somatic symptoms among patients with multiple myeloma.

Materials and Methods A cross-sectional study was performed at our institution among patients with multiple myeloma who had been on treatment for 1 year or more. The study was conducted between July 01 and July 31, 2015. At least 49 patients were required to be recruited into this study to meet its first objective. Patients were administered fear of cancer recurrence inventory (FCRI) questionnaire and Physical Health Questionnaire-15 (PHQ-15) questionnaire.

Results Sixty-four patients participated in the study. The median age was 60 years (34–80 years) and majority were females (N = 38, 60%). ISS staging information was available in 53 (83%) patients. Of 53, 24 (45%) were ISS stage 3, 12 (23%) were ISS stage 2 and remaining stage 1. The mean total FCRI score in the study population was 27.95 (SD: 24.5). Moderate to high levels of FCR were seen in 40% (N = 26). Using PHQ-15, 54 (84%) patients had mild or lesser somatic symptom burden. Disease status of patients at the time of this study had a significant statistical association with PHQ-15 scores (mean score in partial response (PR) or more group 6.02 versus 8.00 in less than PR group, p = 0.02).

Conclusions Overall, FCR scores and somatic symptom severity were low among our patients with multiple myeloma. However, a significant proportion had moderate to high levels of FCR. Further studies involving larger numbers in a prospective manner required to confirm our findings of fear of cancer recurrence among patients with multiple myeloma.

Keywords

fear of recurrence - multiple myeloma - PHQ-15 - FCRI

Ethics Approval and Consent to Participate

Approval was obtained from the Institutional Review Board before the start of the study.


Informed Consent

Informed consent was obtained from all individual participants included in the study.


Ethics

The procedures followed were in accordance with the ethical standards of the IEC and with the Helsinki Declaration of 1964, as revised in 2013. An approval was obtained from the Institutional Review Board (IRB) at Malabar Cancer Center, Thalassery before the start of the study. IRB number – 1616/IRB-SRC/13/MCC/04–07–15/4. Informed consent was obtained from all the patients prior to the study.




Publikationsverlauf

Artikel online veröffentlicht:
01. September 2022

© 2022. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Koch L, Jansen L, Brenner H, Arndt V. Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors–a systematic review of quantitative studies. Psychooncology 2013; 22 (01) 1-11
    CrossrefPubMedSuche in Google Scholar
  • 2 Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 2009; 17 (03) 241-251
    CrossrefPubMedSuche in Google Scholar
  • 3 Vickberg SMJ. The Concerns About Recurrence Scale (CARS): a systematic measure of women's fears about the possibility of breast cancer recurrence. Ann Behav Med 2003; 25 (01) 16-24
    CrossrefPubMedSuche in Google Scholar
  • 4 Hall DL, Jimenez RB, Perez GK. et al. Fear of Cancer Recurrence: A Model Examination of Physical Symptoms, Emotional Distress, and Health Behavior Change. J Oncol Pract 2019; 15 (09) e787-e797
    CrossrefPubMedSuche in Google Scholar
  • 5 Sarkar S, Sautier L, Schilling G, Bokemeyer C, Koch U, Mehnert A. Anxiety and fear of cancer recurrence and its association with supportive care needs and health-care service utilization in cancer patients. J Cancer Surviv 2015; 9 (04) 567-575
    CrossrefPubMedSuche in Google Scholar
  • 6 Simard S, Thewes B, Humphris G. et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 2013; 7 (03) 300-322
    CrossrefPubMedSuche in Google Scholar
  • 7 Fredette SL. Breast cancer survivors: concerns and coping. Cancer Nurs 1995; 18 (01) 35-46
    CrossrefPubMedSuche in Google Scholar
  • 8 Lee-Jones C, Humphris G, Dixon R, Hatcher MB. Fear of cancer recurrence–a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology 1997; 6 (02) 95-105
    CrossrefPubMedSuche in Google Scholar
  • 9 Walburg V, Rueter M, Lamy S. et al. Fear of cancer recurrence in non- and Hodgkin lymphoma survivors during their first three years of survivorship among French patients. Psychol Health Med 2019; 24 (07) 781-787
    CrossrefPubMedSuche in Google Scholar
  • 10 Mehnert A, Koch U, Sundermann C, Dinkel A. Predictors of fear of recurrence in patients one year after cancer rehabilitation: a prospective study. Acta Oncol 2013; 52 (06) 1102-1109
    CrossrefPubMedSuche in Google Scholar
  • 11 Black EK, White CA. Fear of recurrence, sense of coherence and posttraumatic stress disorder in haematological cancer survivors. Psychooncology 2005; 14 (06) 510-515
    CrossrefPubMedSuche in Google Scholar
  • 12 Kumar SK, Dispenzieri A, Lacy MQ. et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia 2014; 28 (05) 1122-1128
    CrossrefPubMedSuche in Google Scholar
  • 13 Hulin C, Hansen T, Heron L. et al. Living with the burden of relapse in multiple myeloma from the patient and physician perspective. Leuk Res 2017; 59: 75-84
    CrossrefPubMedSuche in Google Scholar
  • 14 Ramsenthaler C, Kane P, Gao W. et al. Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis. Eur J Haematol 2016; 97 (05) 416-429
    CrossrefPubMedSuche in Google Scholar
  • 15 Hall DL, Lennes IT, Pirl WF, Friedman ER, Park ER. Fear of recurrence or progression as a link between somatic symptoms and perceived stress among cancer survivors. Support Care Cancer 2017; 25 (05) 1401-1407
    CrossrefPubMedSuche in Google Scholar
  • 16 Kelly M, Dowling M. Patients' lived experience of myeloma. Nurs Stand 2011; 25 (28) 38-44
    CrossrefPubMedSuche in Google Scholar
  • 17 Hu X, Wang W, Wang Y, Liu K. Fear of cancer recurrence in patients with multiple myeloma: Prevalence and predictors based on a family model analysis. Psychooncology 2021; 30 (02) 176-184
    CrossrefPubMedSuche in Google Scholar
  • 18 Tauber NM, O'Toole MS, Dinkel A. et al. Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis. J Clin Oncol 2019; 37 (31) 2899-2915
    CrossrefPubMedSuche in Google Scholar
  • 19 Wani RT. Socioeconomic status scales-modified Kuppuswamy and Udai Pareekh's scale updated for 2019. J Family Med Prim Care 2019; 8 (06) 1846-1849
    CrossrefPubMedSuche in Google Scholar
  • 20 Kroenke K, Spitzer RL, Williams JBW. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 64 (02) 258-266
    CrossrefPubMedSuche in Google Scholar
  • 21 Ghoshal A, Salins N, Damani A. et al. To tell or not to tell: exploring the preferences and attitudes of patients and family caregivers on disclosure of a cancer-related diagnosis and prognosis. J Glob Oncol 2019; 5: 1-12
    CrossrefPubMedSuche in Google Scholar
  • 22 Han PKJ, Gutheil C, Hutchinson RN, LaChance JA. Cause or effect? The role of prognostic uncertainty in the fear of cancer recurrence. Front Psychol 2021; 11: 626038
    CrossrefPubMedSuche in Google Scholar
  • 23 Raphael D, Frey R, Gott M. The nature and timing of distress among post-treatment haematological cancer survivors. Eur J Cancer Care (Engl) 2019; 28 (01) e12951
    CrossrefPubMedSuche in Google Scholar
  • 24 Aderhold C, Morawa E, Paslakis G, Erim Y. Protective factors of depressive symptoms in adult cancer patients: the role of sense of coherence and posttraumatic growth in different time spans since diagnosis. J Psychosoc Oncol 2019; 37 (05) 616-635
    CrossrefPubMedSuche in Google Scholar
  • 25 Mols F, Oerlemans S, Vos AH. et al. Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry. Eur J Haematol 2012; 89 (04) 311-319
    CrossrefPubMedSuche in Google Scholar
  • 26 Ramsenthaler C, Osborne TR, Gao W. et al. The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study. BMC Cancer 2016; 16: 427
    CrossrefPubMedSuche in Google Scholar
  • 27 Mian HS, Pond GR, Wildes TM, Sivapathasundaram B, Sussman J, Seow H. Symptom burden in transplant ineligible patients with newly diagnosed multiple myeloma: a population-based cohort study. Haematologica 2021; 106 (07) 1991-1994
    CrossrefPubMedSuche in Google Scholar
  • 28 Cancer Australia. Recommendations for the identification and management of fear of cancer recurrence in adult cancer survivors. 2014: 1-42
    PubMedSuche in Google Scholar